Dog Owner Dashboard

Treatment

OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis

Summary:

To update and expand upon prior Osteoarthritis Research Society International (OARSI) guidelines by developing patient-focused treatment recommendations for individuals with Knee, Hip, and Polyarticular osteoarthritis (OA) that are derived from expert consensus and based on an objective review of high-quality meta-analytic data.

Conclusion:

These guidelines offer comprehensive and patient-centered treatment profiles for individuals with Knee, Hip, and Polyarticular OA. The treatment algorithm will facilitate individualized treatment decisions regarding the management of OA.

Author & Journal:, R R Bannuru, M C Osani, E E Vaysbrot, N K Arden, K Bennell, S M A Bierma-Zeinstra, V B Kraus, L S Lohmander, J H Abbott, M Bhandari, F J Blanco, R Espinosa, I K Haugen, J Lin, L A Mandl, E Moilanen, N Nakamura, L Snyder-Mackler, T Trojian, M Underwood, T E McAlindon, Osteoarthritis and Cartilage, 2019
Learn More

Canine Hip Dysplasia: Reviewing the Evidence for Nonsurgical Management

Summary:

This systematic review of available evidence for nonsurgical management of hip dysplasia considered 14 articles and scored nonsurgical management including: activity restrictions, weight management, acupuncture, modulation of joint disease by polysulfated glycosaminoglycans, mesenchymal stem cell therapy, and extra corporeal shock wave therapy.

Conclusion:

“Weight management is an effective and important component of managing dogs with HD and associated osteoarthritis. Techniques that modulate the progression of joint disease may also be beneficial for treating dogs with HD. Further studies are needed to investigate other methods of managing HD such as hydrotherapy and physical rehabilitation.”

Author & Journal:Shaw, Kristin Kirkby et al, Veterinary Surgery, 2012
Learn More

Use of client-specific outcome measures to assess treatment effects in geriatric, arthritic dogs: controlled clinical evaluation of a nutraceutical.

Summary:

“A questionnaire method was designed for dog owners to monitor the orthopedic disabilities of their pets for evaluation of a nutraceutical with joint health claims. Fifty large-breed dogs, 7 to 12 years of age, presenting with signs of osteoarthritis, were randomly allocated to placebo and active treatment groups. Degree of disability was assessed by physical examination, a standard questionnaire on daily activities, and a case-specific questionnaire that monitored specific impairments of each dog. The test product was a special milk protein concentrate (SMPC) from hyperimmunized cows, previously shown to express anti inflammatory and antiarthritic activity in humans”

Conclusion:

“Overall improvement was noted in 68% and 35% of the SMPC and placebo groups, respectively.”

Author & Journal:Gingerich D.A., et al, Veterinary Therapeutics, 2003
Learn More